Tech Company Financing Transactions

Galera Therapeutics Funding Round

On 9/21/2018, Galera Therapeutics raised $150 million in Series C financing from Clarus, Adage Capital Management and Correlation Ventures.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Galera plans to use the proceeds of the combined equity and royalty financings to advance the clinical development of GC4419 into and through a pivotal Phase 3 clinical trial for the treatment of severe oral mucositis (SOM) in patients with head and neck cancer, its lead indication.

Company Information

Company Status
Mailing Address
2 West Liberty Blvd. 110
Malvern, PA 19355
Email Address
Not Recorded
Galera Therapeutics (Nasdaq: GRTX) develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Galera Therapeutics LinkedIn Company Profile
Social Media
Galera Therapeutics Company Twitter Account
Company News
Galera Therapeutics News
Galera Therapeutics on Facebook
Galera Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Mel Sorensen
  Mel Sorensen LinkedIn Profile  Mel Sorensen Twitter Account  Mel Sorensen News  Mel Sorensen on Facebook
Chief Financial Officer
Joel Sussman
  Joel Sussman LinkedIn Profile  Joel Sussman Twitter Account  Joel Sussman News  Joel Sussman on Facebook
Chief Medical Officer
Jon Holmlund
  Jon Holmlund LinkedIn Profile  Jon Holmlund Twitter Account  Jon Holmlund News  Jon Holmlund on Facebook
Chief Operating Officer
Robert Beardsley
  Robert Beardsley LinkedIn Profile  Robert Beardsley Twitter Account  Robert Beardsley News  Robert Beardsley on Facebook
Chief Scientific Officer
Dennis Riley
  Dennis Riley LinkedIn Profile  Dennis Riley Twitter Account  Dennis Riley News  Dennis Riley on Facebook
VP - Bus. Development
Arthur Fratamico
  Arthur Fratamico LinkedIn Profile  Arthur Fratamico Twitter Account  Arthur Fratamico News  Arthur Fratamico on Facebook
VP - Bus. Development
Stephen Ross
  Stephen Ross LinkedIn Profile  Stephen Ross Twitter Account  Stephen Ross News  Stephen Ross on Facebook



Browse more venture capital transactions:

Prev: 9/21/2018: WalkMe venture capital transaction
Next: 9/21/2018: Providence Medical Technology venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary